Antimalarial subsidy
Showing 1 - 25 of 237
Malaria, Febrile Illness Trial in Lagos (Testing incentive, Conditional artemisinin combination therapy subsidy)
Recruiting
- Malaria
- Febrile Illness
- Testing incentive
- Conditional artemisinin combination therapy subsidy
-
Lagos, NigeriaClinton Health Access Initiative
Feb 4, 2022
Blood Pressure, Lung Function Trial in Ndego (Clean household energy)
Recruiting
- Blood Pressure
- Lung Function
- Clean household energy
-
Ndego, Eastern Province, RwandaField site in Rwanda (Isangano and Karambi)
Dec 19, 2022
Diabetes, Type 2 Trial in Chapel Hill (MTM, Food Subsidy)
Recruiting
- Diabetes Mellitus, Type 2
- MTM
- Food Subsidy
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Dec 6, 2022
Overweight Trial in Singapore (Subsidy Treatment, Cash Treatment)
Recruiting
- Overweight
- Subsidy Treatment
- Cash Treatment
-
Singapore, SingaporeNational University of Singapore
Apr 24, 2022
Malaria Genetic Surveillance in Cambodia
Completed
- Parasitology
- +2 more
- (no location specified)
May 17, 2022
Anemia, Iron Deficiency Anemia Trial in Palembang (Iron Supplement Tablets)
Completed
- Anemia
- Iron Deficiency Anemia
- Iron Supplement Tablets
-
Palembang, South Sumatera, IndonesiaAnita Rahmiwati
Aug 19, 2023
Malaria Trial (Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP)
Not yet recruiting
- Malaria
- Pyronaridine Tetraphosphate, Artesunate Drug Combination
- +4 more
- (no location specified)
Jun 27, 2022
Homeless Persons Trial in Toronto (Mentorship, Rent Subsidies)
Completed
- Homeless Persons
- Mentorship
- Rent Subsidies
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Sep 1, 2022
Fever, Malaria Trial in Eldoret (Malaria RDT & conditional voucher for ACT from retail sector)
Completed
- Fever
- Malaria
- Malaria RDT & conditional voucher for ACT from retail sector
-
Eldoret, KenyaMoi University
Oct 8, 2019
Malaria Genetic Surveillance
Recruiting
- Plasmodium Falciparum and Plasmodium Vivax
-
Phnom Penh, Cambodia
- +2 more
Mar 22, 2022
Malaria, Malaria,Falciparum Trial in Ouagadougou (Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH
Not yet recruiting
- Malaria
- Malaria,Falciparum
- Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- +2 more
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
May 18, 2023
l Antimalarial Drugs, Malaria Vaccines, and Controlled Human
Recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,
Recruiting
- Uncomplicated Plasmodium Falciparum Malaria
-
Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
- +7 more
Oct 7, 2023
Malaria,Falciparum Trial (Artemether-lumefantrine (AL), Dihydroartemisinin-piperaquine (DP))
Completed
- Malaria,Falciparum
- Artemether-lumefantrine (AL)
- Dihydroartemisinin-piperaquine (DP)
- (no location specified)
Sep 27, 2021
Toxicity, Drug, Maculopathy Trial in Paris (spectral domain optical coherence tomography C-scan and multifocal
Completed
- Toxicity, Drug
- Maculopathy
- spectral domain optical coherence tomography C-scan and multifocal electroretinogram
-
Paris, FranceFondation Ophtalmique Adolphe de Rothschild
Dec 17, 2021
Efficacy, Malaria, Chloroquine Trial in Arba Minch (Chloroquine, Primaquine)
Completed
- Efficacy
- +3 more
-
Arba Minch, South Ethiopia, EthiopiaShecha Health Center
Sep 19, 2023
Malaria Trial in Nanoro (Sulfadoxine pyrimethamine, Amodiaquine)
Recruiting
- Malaria
- Sulfadoxine pyrimethamine
- Amodiaquine
-
Nanoro, Burkina FasoUnité de Recherche Clinique de Nanoro
Jul 26, 2022
Malaria Trial in Allschwil (14C-labeled Pyronaridine)
Completed
- Malaria
- 14C-labeled Pyronaridine
-
Allschwil, Basel, SwitzerlandCovance Clinical Research Unit AG
Nov 18, 2021
Malaria, Febrile Illness Trial in Eldoret (Conditional ACT subsidy, Arm 1 levels, Conditional ACT subsidy, Arm 2 levels,
Completed
- Malaria
- Febrile Illness
- Conditional ACT subsidy, Arm 1 levels
- +3 more
-
Eldoret, KenyaMoi University
Oct 20, 2020
Hypertension, Food Insecurity, Diet, Mediterranean Trial in Chapel Hill (Food Subsidy, 6 months, Food Subsidy, 12 months,
Enrolling by invitation
- Hypertension
- +2 more
- Food Subsidy, 6 months
- +5 more
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Oct 8, 2021
Sanitation Trial in Tamale (Targeted Subsidy)
Completed
- Sanitation
- Targeted Subsidy
-
Tamale, GhanaDistricts of Tatale and Kpandai, Northern Region
Oct 1, 2021
Plasmodium Falciparum Antimalarial Drug Resistance Markers
Completed
- Plasmodium Falciparum
-
Kome, Doba, ChadStudy clinic
Mar 29, 2022
ERASE - Impact of COVID-19 on Malaria Control
Not yet recruiting
- Malaria
- Malaria in Pregnancy
- Advanced Analysis of Polymorphism
- (no location specified)
Apr 25, 2022
Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))
Not yet recruiting
- Lupus Erythematosus, Cutaneous, Subacute
- Chronic Cutaneous Lupus Erythematosus
- BIIB059 (litifilimab)
- (no location specified)
Sep 12, 2023
Monitoring Pregnant Women for Antimalarial Drug Resistance
Recruiting
- Malaria
- Malaria screening
-
Kinsasa, Congo, The Democratic Republic of theKinshasa Medical Oxford Research Unit
Nov 25, 2021